Acorda Shares Continue To Skyrocket, Up Another 32%
Shares of Acorda Therapeutics (ACOR) continued their substantial jump with another big gain, ending the trading session up 32% to $11.50.
On Monday, September the 25th Shares of the small biotech almost quadrupled as the company announced its Multiple Sclerosis drug showed marked imporvement in the walking speed of patients (please read BHI's commentary on Acorda and investing in Biotech).
Tuesday's jump in Acorda's stock price was realized on 8x average daily volume, with more than 8 million shares trading hands.
_
Shares of Acorda Therapeutics (ACOR) continued their substantial jump with another big gain, ending the trading session up 32% to $11.50.
On Monday, September the 25th Shares of the small biotech almost quadrupled as the company announced its Multiple Sclerosis drug showed marked imporvement in the walking speed of patients (please read BHI's commentary on Acorda and investing in Biotech).
Tuesday's jump in Acorda's stock price was realized on 8x average daily volume, with more than 8 million shares trading hands.
_
posted by Nico at
7:39 PM
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home